Austin, Texas — 04/02/2019 — Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy-to-use products for complex testing in genetics and oncology, today announced a substantial
300 Montgomery Street
Suite 1130
San Francisco, CA 94104